Ondansetron
1 clinical trial
1 abstract
1 indication
Indication
Postoperative Nausea and VomitingAbstract
Real-world analysis of cardiac, gastrointestinal, and hematologic toxicities between commonly used antiemetics in everyday oncology clinical practice.Org: Louisiana State University in Shreveport, Feist-Weiller Cancer Center at LSUHSC-Shreveport, LSU Health Shreveport,
Clinical trial
A Evaluate HRS5580 for Injection for Prevention of Postoperative Nausea and Vomiting Efficacy and Safety of Ⅱ Period, Randomized, Multicenter, Dose of Exploration, Positive Control, Placebo-controlled, Double-blind, Double Simulation TrialsStatus: Not yet recruiting, Estimated PCD: 2024-10-01